• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

患者报告结局量表(PROM)给药方法对中风幸存者的可接受性:一项随机对照试验方案

Acceptability of the method of administration of a patient-reported outcome measure (PROM) with stroke survivors, a randomised controlled trial protocol.

作者信息

Smith Alexander, Pennington Anna, Carter Ben, Gething Stephanie, Price Michelle, White James, Dewar Richard, Hewitt Jonathan

机构信息

Aneurin Bevan University Health Board, South Wales, UK.

Department of Biostatistics and Health Informatics, Institute of Psychiatry, Psychology & Neuroscience, King's College London, London, UK.

出版信息

Trials. 2018 Jul 3;19(1):349. doi: 10.1186/s13063-018-2694-4.

DOI:10.1186/s13063-018-2694-4
PMID:29970156
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6030753/
Abstract

BACKGROUND

UK-wide national clinical guidelines promote routine 6-month post-stroke follow-up assessment. However, as part of this 6-month assessment little information is gathered from the patient's perspective. The means of collecting this patient-centred information might be served best by a patient-reported outcome measure (PROM) at the 6-month assessment time point. Currently, four different methods of 6-month follow-up assessment occur; the most common being face-to-face interview followed by telephone interview, postal questionnaire and online questionnaire. Therefore, this study will investigate if the acceptability of telephone, online or postal administration of a PROM at the 6-month post-stoke time point is not inferior to face-to-face administration.

METHODS/DESIGN: A UK multicentre, blinded (analyst and researcher), pragmatic, non-inferiority study, with 80% power using a 2.5% non-inferiority margin was designed to compare the acceptability of three modes of administration (telephone interview, postal questionnaire and online questionnaire) compared with face-to-face interview administration of a PROM. We plan to approach and randomise a minimum of 808 potentially eligible participants, 202 participants per group.

DISCUSSION

The aim of this ongoing research is to understand if there is a difference between face-to-face administration and the other three methods of administering a PROM as a patient-centred supplement to the 6-month review for stroke survivors. In utilising a pragmatic design, it is believed that this study will offer UK wide generalisable results, of the acceptability of the methods under investigation, to inform clinicians and commissioners of stroke services.

TRIALS REGISTRATION

ClinicalTrials.gov: NCT03177161 . Registered on 6 June 2017.

摘要

背景

全英国范围的国家临床指南提倡在中风后进行常规的6个月随访评估。然而,在这6个月的评估中,从患者角度收集的信息很少。在6个月评估时间点采用患者报告结局量表(PROM)可能是收集这种以患者为中心信息的最佳方式。目前,有四种不同的6个月随访评估方法;最常见的是面对面访谈,其次是电话访谈、邮寄问卷和在线问卷。因此,本研究将调查在中风后6个月时间点通过电话、在线或邮寄方式进行PROM评估的可接受性是否不低于面对面评估。

方法/设计:一项英国多中心、双盲(分析人员和研究人员)、实用、非劣效性研究,设计为使用2.5%的非劣效性界值,检验效能为80%,旨在比较三种评估方式(电话访谈、邮寄问卷和在线问卷)与PROM面对面访谈评估的可接受性。我们计划纳入并随机分配至少808名潜在符合条件的参与者,每组202名参与者。

讨论

这项正在进行的研究的目的是了解作为中风幸存者6个月复查以患者为中心的补充内容,面对面评估与其他三种PROM评估方法之间是否存在差异。通过采用实用设计,相信本研究将提供全英国范围内关于所研究方法可接受性的可推广结果,为中风服务的临床医生和管理人员提供参考。

试验注册

ClinicalTrials.gov:NCT03177161。于2017年6月6日注册。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cb76/6030753/706ca43514e6/13063_2018_2694_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cb76/6030753/b3f19c698501/13063_2018_2694_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cb76/6030753/706ca43514e6/13063_2018_2694_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cb76/6030753/b3f19c698501/13063_2018_2694_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cb76/6030753/706ca43514e6/13063_2018_2694_Fig2_HTML.jpg

相似文献

1
Acceptability of the method of administration of a patient-reported outcome measure (PROM) with stroke survivors, a randomised controlled trial protocol.患者报告结局量表(PROM)给药方法对中风幸存者的可接受性:一项随机对照试验方案
Trials. 2018 Jul 3;19(1):349. doi: 10.1186/s13063-018-2694-4.
2
A multi-centre, UK-based, non-inferiority randomised controlled trial of 4 follow-up assessment methods in stroke survivors.一项多中心、基于英国的、非劣效性随机对照试验,比较了 4 种随访评估方法在脑卒中幸存者中的应用。
BMC Med. 2019 Jul 2;17(1):111. doi: 10.1186/s12916-019-1350-5.
3
Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.在流行地区,服用抗叶酸抗疟药物的人群中,叶酸补充剂与疟疾易感性和严重程度的关系。
Cochrane Database Syst Rev. 2022 Feb 1;2(2022):CD014217. doi: 10.1002/14651858.CD014217.
4
An intervention to support stroke survivors and their carers in the longer term (LoTS2Care): study protocol for a cluster randomised controlled feasibility trial.一项长期支持中风幸存者及其护理人员的干预措施(LoTS2Care):一项整群随机对照可行性试验的研究方案
Trials. 2018 Jun 11;19(1):317. doi: 10.1186/s13063-018-2669-5.
5
Virtualized clinical studies to assess the natural history and impact of gut microbiome modulation in non-hospitalized patients with mild to moderate COVID-19 a randomized, open-label, prospective study with a parallel group study evaluating the physiologic effects of KB109 on gut microbiota structure and function: a structured summary of a study protocol for a randomized controlled study.用于评估非住院轻中度 COVID-19 患者肠道微生物组调节的自然史和影响的虚拟化临床研究:一项随机、开放标签、前瞻性研究,平行组研究评估 KB109 对肠道微生物组结构和功能的生理影响:一项随机对照研究方案的结构化总结。
Trials. 2021 Apr 2;22(1):245. doi: 10.1186/s13063-021-05157-0.
6
An extended stroke rehabilitation service for people who have had a stroke: the EXTRAS RCT.一项针对中风患者的扩展中风康复服务:EXTRAS RCT。
Health Technol Assess. 2020 May;24(24):1-202. doi: 10.3310/hta24240.
7
An individually randomised controlled multi-centre pragmatic trial with embedded economic and process evaluations of early vocational rehabilitation compared with usual care for stroke survivors: study protocol for the RETurn to work After stroKE (RETAKE) trial.一项针对中风幸存者的早期职业康复与常规护理的个体随机对照多中心实用试验,其中嵌入了经济和过程评估:RETAKE 试验(中风后重返工作岗位研究)研究方案。
Trials. 2020 Dec 9;21(1):1010. doi: 10.1186/s13063-020-04883-1.
8
A pragmatic randomised controlled trial of the effectiveness and cost-effectiveness of 'PhysioDirect' telephone assessment and advice services for physiotherapy.“PhysioDirect”电话评估和咨询服务对物理治疗有效性和成本效益的实用随机对照试验。
Health Technol Assess. 2013 Jan;17(2):1-157, v-vi. doi: 10.3310/hta17020.
9
Organising Support for Carers of Stroke Survivors (OSCARSS): study protocol for a cluster randomised controlled trial, including health economic analysis.为中风幸存者照料者提供组织支持(OSCARSS):一项整群随机对照试验的研究方案,包括卫生经济学分析。
Trials. 2019 Jan 7;20(1):19. doi: 10.1186/s13063-018-3104-7.
10
Synthetic sling or artificial urinary sphincter for men with urodynamic stress incontinence after prostate surgery: the MASTER non-inferiority RCT.前列腺手术后尿动力学压力性尿失禁男性患者使用合成吊带或人工尿道括约肌:MASTER 非劣效 RCT。
Health Technol Assess. 2022 Aug;26(36):1-152. doi: 10.3310/TBFZ0277.

引用本文的文献

1
Electronic Sports Sustainable Development of Probing into Digital Games, Teenage Domestication, and Mutual Construction.电子竞技可持续发展:探究数字游戏、青少年驯化和相互建构。
J Environ Public Health. 2022 Jul 14;2022:6375787. doi: 10.1155/2022/6375787. eCollection 2022.
2
Routine provision of feedback from patient-reported outcome measurements to healthcare providers and patients in clinical practice.在临床实践中,常规向医疗保健提供者和患者提供来自患者报告的结局测量的反馈。
Cochrane Database Syst Rev. 2021 Oct 12;10(10):CD011589. doi: 10.1002/14651858.CD011589.pub2.
3
The Use of Patient Reported Outcome Measures (PROMs) 6 Months Post-Stroke and Their Association with the National Institute of Health Stroke Scale (NIHSS) on Admission to Hospital.

本文引用的文献

1
EQ-5D and the EuroQol Group: Past, Present and Future.EQ-5D与欧洲生活质量小组:过去、现在与未来。
Appl Health Econ Health Policy. 2017 Apr;15(2):127-137. doi: 10.1007/s40258-017-0310-5.
2
Cognitive rehabilitation for memory deficits after stroke.中风后记忆缺陷的认知康复
Cochrane Database Syst Rev. 2016 Sep 1;9(9):CD002293. doi: 10.1002/14651858.CD002293.pub3.
3
Validation of Hospital Performance Measures of Acute Stroke Care Quality. Riksstroke, the Swedish Stroke Register.急性中风护理质量医院绩效指标的验证。瑞典中风登记处Riksstroke。
中风后6个月患者报告结局量表(PROMs)的应用及其与入院时国立卫生研究院卒中量表(NIHSS)的相关性。
Geriatrics (Basel). 2021 Sep 7;6(3):88. doi: 10.3390/geriatrics6030088.
4
Distress screening and supportive care referrals used by telephone-based health services: a systematic review.基于电话的健康服务中使用的困扰筛查和支持性护理转介:系统评价。
Support Care Cancer. 2020 May;28(5):2059-2069. doi: 10.1007/s00520-019-05252-8. Epub 2019 Dec 24.
5
A multi-centre, UK-based, non-inferiority randomised controlled trial of 4 follow-up assessment methods in stroke survivors.一项多中心、基于英国的、非劣效性随机对照试验,比较了 4 种随访评估方法在脑卒中幸存者中的应用。
BMC Med. 2019 Jul 2;17(1):111. doi: 10.1186/s12916-019-1350-5.
Neuroepidemiology. 2016;46(4):229-34. doi: 10.1159/000444679. Epub 2016 Mar 15.
4
An International Standard Set of Patient-Centered Outcome Measures After Stroke.一套国际标准的卒中后以患者为中心的结局指标
Stroke. 2016 Jan;47(1):180-6. doi: 10.1161/STROKEAHA.115.010898. Epub 2015 Nov 24.
5
The routine collection of patient-reported outcome measures (PROMs) for long-term conditions in primary care: a cohort survey.基层医疗中针对慢性病的患者报告结局测量指标(PROMs)的常规收集:一项队列研究。
BMJ Open. 2014 Feb 21;4(2):e003968. doi: 10.1136/bmjopen-2013-003968.
6
The case for an international patient-reported outcomes measurement information system (PROMIS®) initiative.支持建立国际患者报告结局测量信息系统(PROMIS®)倡议。
Health Qual Life Outcomes. 2013 Dec 20;11:210. doi: 10.1186/1477-7525-11-210.
7
Telephone follow-up was more expensive but more efficient than postal in a national stroke registry.电话随访比邮政在国家卒中登记处更昂贵,但更有效。
J Clin Epidemiol. 2013 Aug;66(8):896-902. doi: 10.1016/j.jclinepi.2013.03.005.
8
SPIRIT 2013 explanation and elaboration: guidance for protocols of clinical trials.SPIRIT 2013 解释和说明:临床试验方案指南。
BMJ. 2013 Jan 8;346:e7586. doi: 10.1136/bmj.e7586.
9
SPIRIT 2013 statement: defining standard protocol items for clinical trials.SPIRIT 2013 声明:定义临床试验的标准议定书项目。
Ann Intern Med. 2013 Feb 5;158(3):200-7. doi: 10.7326/0003-4819-158-3-201302050-00583.
10
Reporting of noninferiority and equivalence randomized trials: extension of the CONSORT 2010 statement.非劣效性和等效性随机试验报告:CONSORT 2010 声明的扩展。
JAMA. 2012 Dec 26;308(24):2594-604. doi: 10.1001/jama.2012.87802.